More Sources?

The hunt continues for more sources.

Usually, finding sources for a topic is fairly easy. There are a gazillion sources out there on transgenic animals right?

Well that's what I thought until I was searching for sources that narrowed down to transgenic animals and their role in the research of neurodegenerative diseases.
Whenever the topic of writing a paper comes up with my friends, I tell them what my topic is. Before I can even get past saying "transgenic mice and their..." they cut me off with a look of displeasure and mercy. Frankly, I find this topic quite interesting and bearable with the exception of finding sources.
The topic of transgenic animals is broad. In the beginning of my research, I simply typed in "Transgenic Animals" into the search bar and thousands of scholarly sources came up. Yes, scholarly. The topics of these sources were quite broad, which is how I found my topic for the paper. I settled with transgenic animals and neurodegenerative diseases. I started to scout for more sources for my research since I do need at least 5 scholarly, peer-reviewed sources. Entering "Transgenic Animals and Neurodegenerative diseases" only gave me hundreds of sources. This number decreased as I filtered the results.

After an accumulation of several hours, I have five solid scholarly sources so far.
The two I have not shared yet on this blog are "Transgenic animal models of Alzehimer's disease and related disorders: histopathology, behavior and therapy" by J Götz et al. and "Alpha-synuclein and transgenic mouse models" by Pierre-Oliver Fernagut and Marie-Fancoise Chesselet.
Both of these sources explain the research and discoveries made with transgenic mice.

Götz et al. wrote "Transgenic animal models of Alzehimer's disease and related disorders: histopathology, behavior and therapy"in 2004 before A Decade of Tau Transgenic Animal Models and Beyond was written in 2007, which I talked about in a previous post, Neurodegenerative Diseases. In his earlier paper, Götz et al. not only focuses on tau transgenic mice, but also β-Amyloid transgenic mice. Here, β-Amyloid mice were used to observe the relationship between the amount of β-Amyloid present in the brain and memory impairment. The β-Amlyoid mice confirmed their theory. Mice with greater levels of β-Amlyoid in the brain resulted in greater memory impairment. This is a great finding because it lets researchers know what is associated with memory impairment, one of the greatest and most dangerous symptoms of Alzheimer's. Thanks to transgenic mice, researchers can now utilize this knowledge to move to the next step into the finding a cure for Alzheimer's.

In "Alpha-synuclein and transgenic mouse models," Fernagut and Chesselet used transgenic mice for researching Parkinson Disease. Unlike the other sources I am using, this one is not about the findings of how transgenic mice have made a contribution to learning more about Parkinson Disease. The animals did not display what the researchers hoped the mice would. Fernagut and Chesselet expected dopaminergic neuronal death in the substantial nigra. But instead, the mice expressed inconclusive results of the relationship between α-syn and dopamine dysfunction. Despite the failure in their experiment, Fernagut and Chesselet were still satisfied with the mice models and will remain to use transgenic animals for alternatives. The models captured the features and characteristics of Parkinson Disease. Researchers find this relevant and important because these mice can be used to test another hypothesis that increased levels of α-syn predispose relating to the development of the diseases. The mice will be used to receive a better understanding of α-syn. 

I found these sources to be quite useful in my paper for they will support my argument of the contributions that transgenic mice have made to the researching of neurodegenerative diseases. I will continue to share more sources in the following post or two.